Compare · ALGN vs ZJYL
ALGN vs ZJYL
Side-by-side comparison of Align Technology Inc. (ALGN) and JIN MEDICAL INTERNATIONAL LTD. (ZJYL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and ZJYL operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.32B, about 699.6x ZJYL ($17.6M).
- Over the past year, ALGN is down 1.6% and ZJYL is down 82.6% - ALGN leads by 81.0 points.
- ALGN has been more active in the news (16 items in the past 4 weeks vs 1 for ZJYL).
- ALGN has more recent analyst coverage (25 ratings vs 0 for ZJYL).
- Company
- Align Technology Inc.
- JIN MEDICAL INTERNATIONAL LTD.
- Price
- $178.02+3.42%
- $2.44-15.40%
- Market cap
- $12.32B
- $17.6M
- 1M return
- +5.51%
- +16.43%
- 1Y return
- -1.64%
- -82.63%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2023
- News (4w)
- 16
- 1
- Recent ratings
- 25
- 0
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Latest ALGN
- Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
- SEC Form SD filed by Align Technology Inc.
- Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)
- Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)
- Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)
- Director Poul Mojdeh converted options into 1,745 shares, increasing direct ownership by 97% to 3,553 units (SEC Form 4)
- Director Myong Anne converted options into 1,745 shares, increasing direct ownership by 22% to 9,830 units (SEC Form 4)
- Director Larkin C Raymond Jr converted options into 2,326 shares, increasing direct ownership by 9% to 27,454 units (SEC Form 4)
- Director Dallas Kevin J converted options into 1,745 shares, increasing direct ownership by 12% to 16,168 units (SEC Form 4)
- Director Lacob Joseph converted options into 1,745 shares (SEC Form 4)
Latest ZJYL
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- SEC Form 3 filed by new insider Franklin Oliver St Clair Jr
- SEC Form 3 filed by new insider Tong James Jiayuan
- SEC Form 3 filed by new insider Guo Yanru
- New insider Wang Erqi claimed ownership of 4,306,307 units of Class A Ordinary Shares and claimed ownership of 1,000,000 units of Class B Ordinary Shares (SEC Form 3)
- SEC Form 3 filed by new insider Wang Ziqiang
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative